Oxford, United Kingdom

Phil T Price

This inventor holds 2 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2003-2004.


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 127(Granted Patents)


Company Filing History:


Years Active: 2003-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Phil T Price: Innovator in Dispensing Technology

Introduction

Phil T Price is a notable inventor based in Oxford, GB. He has made significant contributions to the field of dispensing technology, holding a total of 2 patents. His work focuses on creating devices that enhance the efficiency and accuracy of liquid dispensing.

Latest Patents

Among his latest patents is a dispensing device designed for dispensing a measured dose of liquid from an attached container. This device features an elongate casing that defines a dispensing cylinder, with one end adapted for mounting on the container. The casing includes a plurality of dose indications on its external surface, allowing users to pre-select a dose by moving a dose setting collar along the casing. The collar is equipped with a stop that engages with selected recesses on the casing to secure it in place. A plunger, which cooperates with a piston within the cylinder, is movable to charge the dispenser and dispense the selected dose from an outlet port.

Career Highlights

Phil T Price is currently associated with Novartis AG, a leading global healthcare company. His innovative work in dispensing technology has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Phil has collaborated with talented individuals such as Stephanie Bley and Bernard Sams, contributing to advancements in their respective fields.

Conclusion

Phil T Price's contributions to dispensing technology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…